Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dezhi Sui
Institution:
Eastern Liaoning University
Observed institutions:
Shenyang Pharmaceutical University,
Eastern Liaoning University
ORCID:
0009-0005-1705-0105
Observed ORCID:
0009-0005-1705-0105
OpenAlex ID:
A5066058837
Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy
2021
·
Junqiang Ding
, Dezhi Sui
, et al.
·
Acta Biomaterialia
·
64
Simultaneous dendritic cells targeting and effective endosomal escape enhance sialic acid-modified mRNA vaccine efficacy and reduce side effects
2023
·
Xueying Tang
, Jiashuo Zhang
, et al.
·
Journal of Controlled Release
·
61
Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages – A promising cancer immunotherapy
2020
·
Xueying Tang
, Dezhi Sui
, et al.
·
International Journal of Pharmaceutics
·
40
Cleavable-Branched Polymer-Modified Liposomes Reduce Accelerated Blood Clearance and Enhance Photothermal Therapy
2023
·
Dezhi Sui
, Yujie Wang
, et al.
·
ACS Applied Materials & Interfaces
·
27
Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity
2021
·
Dezhi Sui
, Xueying Tang
, et al.
·
International Journal of Pharmaceutics
·
27
Sialic acid-mediated photochemotherapy enhances infiltration of CD8+ T cells from tumor-draining lymph nodes into tumors of immunosenescent mice
2022
·
Dezhi Sui
, Changzhi Li
, et al.
·
Acta Pharmaceutica Sinica B
·
18
PDF
Optimization design of sialic acid derivatives enhances the performance of liposomes for modulating immunosuppressive tumor microenvironments
2022
·
Dezhi Sui
, Kaifan Liang
, et al.
·
Life Sciences
·
14
The Fate of Sialic Acid and PEG Modified Epirubicin Liposomes in Aged versus Young Cells and Tumor Mice Models
2022
·
Dezhi Sui
, Xianmin Meng
, et al.
·
Pharmaceutics
·
12
PDF
Asymmetrical branched PEG-modified liposomes evade anti-PEG antibody recognition to abolish accelerated blood clearance and amplify tumor drug accumulation
2025
·
Kunfeng Zhang
, Mingze Li
, et al.
·
Nanoscale
·
10
A potential platform of combining sialic acid derivative-modified paclitaxel cationic liposomes with antibody–drug conjugates inspires robust tumor-specific immunological memory in solid tumors
2023
·
Wenliang Sun
, Yantong Li
, et al.
·
Biomaterials Science
·
10
Durable protective efficiency provide by mRNA vaccines require robust immune memory to antigens and weak immune memory to lipid nanoparticles
2024
·
Xueying Tang
, Jiashuo Zhang
, et al.
·
Materials Today Bio
·
9
An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid–Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis
2022
·
Xianmin Meng
, Mingqi Wang
, et al.
·
AAPS PharmSciTech
·
9
Combination therapy with lipid prodrug liposomes reshapes disease-associated neutrophils to promote the cancer-immunity cycle
2025
·
Dezhi Sui
, Yanzhi Song
, et al.
·
Journal of Nanobiotechnology
·
7
Transformable binary-prodrug nanoparticles harness heterogeneity of neutrophils to overcome multidrug resistance and promote pyroptosis in cancer
2024
·
Dezhi Sui
, Kaituo Zhang
, et al.
·
Applied Materials Today
·
4
Disease-associated neutrophil heterogeneity in cancer therapy: Implications for precision immunotherapy
2026
·
Dezhi Sui
, Fei Liu
, et al.
·
Critical Reviews in Oncology/Hematology
·
3
Sialic acid-modified doxorubicin liposomes target tumor-related immune cells to relieve multiple inhibitions of CD8 + T cells
2024
·
Zhouchunxiao Du
, Dezhi Sui
, et al.
·
Journal of Liposome Research
·
3
Recent advances in sialic acid-based active targeting chemoimmunotherapy promoting tumor shedding: a systematic review
2024
·
Jingyi Zhao
, Kunfeng Zhang
, et al.
·
Nanoscale
·
3
Targeting of TAMs with freeze-dried monosialotetrahexosylganglioside and sialic acid-octadecylamine co-modified liposomes remodels the tumor microenvironment and enhances anti-tumor activity
2023
·
Lu Wei
, Dan Zhao
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
3
A combination therapy with “optimus prime” tumor inhibition index: co-delivery of melittin and doxorubicin mediated by polysialic acid-siglec-1 axis induces tumor exfoliation
2025
·
Yuanyuan Lu
, Ying Qin
, et al.
·
Journal of Drug Delivery Science and Technology
·
1
Asymmetrical Branched Polyethylene Glycol (PEG) Modification Reduces Anti-PEG Antibody Binding to Enhance Liposomal Anti-Tumor Therapy
2024
·
Dezhi Sui
, Mingze Li
, et al.
·
1
PDF
Antitumor Immunotherapy of Sialic Acid and/or GM1 Modified Coenzyme Q10 Submicron Emulsion
2022
·
Xianmin Meng
, Na Yan
, et al.
·
AAPS PharmSciTech
·
1
Delivery strategies and mechanisms of medicinal and edible fungal polysaccharide-based antitumor functional foods
2026
·
Tongyu Meng
, Jie Song
, et al.
·
Applied Food Research
PDF
Polysaccharide-Based Approaches for Inflammation Treatment: Anti-Inflammatory Mechanisms, Delivery Approaches and Translational Prospects
2026
·
Xiaoyu Ren
, Yuan Zhou
, et al.
·
Biomolecules
Show more works
View as search
Works count:
23
Citation count:
327
H-index:
10
I10-index:
10
Year
Topic
Type
